Literature DB >> 8332562

The boundaries of schizophrenia.

L J Siever1, O F Kalus, R S Keefe.   

Abstract

Evidence from a variety of domains including the phenomenologic, genetic, psychological, neuropsychological, psychophysiologic, neurochemical, imaging, outcome, and treatment response suggests that schizotypal personality disorder is related closely to chronic schizophrenia and that this disorder may be part of a continuum of schizophrenia-related disorders. Questions remain as to how the boundaries of schizophrenia should be defined. The commonalities across the schizophrenia spectrum as well as the differences between disorders on the spectrum need to be clarified further. A multidimensional approach to the pathogenesis of the schizophrenia-related disorders offers a beginning opportunity for such a clarification. The study of patients with schizotypal personality disorder suggest that a dimension of deficit-like or "negative" symptoms of asociality and interpersonal impairment may be associated with neuropsychological and psychophysiologic correlates of altered cortical, particularly frontal, function and raise the possibility in structural changes as reflected in increased ventricular size in frontal and third ventricle areas. On the other hand, the psychotic-like or "positive" symptoms seem to be more related to increases in dopaminergic activity that may be partially responsive to neuroleptic treatment. It is conceivable that these two dimensions may represent partially distinct but potentially interactive pathophysiologic processes that may converge and interact to result in chronic schizophrenia. In this way, the study of the boundaries of schizophrenia and the milder schizophrenia-related personality disorders may provide important clues as to the genetic and pathophysiology of chronic schizophrenia itself, as well as to illuminate a set of disorders that are clinically underrecognized but probably more prevalent than more severe forms of schizophrenia.

Entities:  

Mesh:

Year:  1993        PMID: 8332562

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  19 in total

1.  MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder.

Authors:  James J Levitt; Robert W McCarley; Chandlee C Dickey; Martina M Voglmaier; Margaret A Niznikiewicz; Larry J Seidman; Yoshio Hirayasu; Aleksandra A Ciszewski; Ron Kikinis; Ferenc A Jolesz; Martha E Shenton
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

2.  Neurocognitive deficits in the (putative) prodrome and first episode of psychosis.

Authors:  A D Eastvold; R K Heaton; K S Cadenhead
Journal:  Schizophr Res       Date:  2007-04-30       Impact factor: 4.939

3.  Orbitofrontal sulcogyral pattern and olfactory sulcus depth in the schizophrenia spectrum.

Authors:  Yumiko Nishikawa; Tsutomu Takahashi; Yoichiro Takayanagi; Atsushi Furuichi; Mikio Kido; Mihoko Nakamura; Daiki Sasabayashi; Kyo Noguchi; Michio Suzuki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-11       Impact factor: 5.270

4.  Reduced Cortical Thickness in Schizophrenia and Schizotypal Disorder.

Authors:  Yoichiro Takayanagi; Daiki Sasabayashi; Tsutomu Takahashi; Atsushi Furuichi; Mikio Kido; Yumiko Nishikawa; Mihoko Nakamura; Kyo Noguchi; Michio Suzuki
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

5.  Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.

Authors:  Erin A Hazlett; Ethan G Rothstein; Rui Ferreira; Jeremy M Silverman; Larry J Siever; Ann Olincy
Journal:  Schizophr Res       Date:  2014-12-05       Impact factor: 4.939

6.  Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients.

Authors:  Erin A Hazlett; Monte S Buchsbaum; M Mehmet Haznedar; Randall Newmark; Kim E Goldstein; Yuliya Zelmanova; Cathryn F Glanton; Yuliya Torosjan; Antonia S New; Jennifer N Lo; Vivian Mitropoulou; Larry J Siever
Journal:  Schizophr Res       Date:  2008-02-13       Impact factor: 4.939

7.  Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder.

Authors:  James J Levitt; Carl Fredrik Westin; Paul G Nestor; Raul S J Estepar; Chandlee C Dickey; Martina M Voglmaier; Larry J Seidman; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley; Martha E Shenton
Journal:  Biol Psychiatry       Date:  2004-01-15       Impact factor: 13.382

8.  Nonverbal delayed recognition in the relatives of schizophrenia patients with or without schizophrenia spectrum.

Authors:  Olalla Robles; Teresa Blaxton; Helene Adami; Celso Arango; Gunvant Thaker; James Gold
Journal:  Biol Psychiatry       Date:  2007-10-03       Impact factor: 13.382

9.  Shape abnormalities of caudate nucleus in schizotypal personality disorder.

Authors:  James J Levitt; Martin Styner; Marc Niethammer; Sylvain Bouix; Min-Seong Koo; Martina M Voglmaier; Chandlee C Dickey; Margaret A Niznikiewicz; Ron Kikinis; Robert W McCarley; Martha E Shenton
Journal:  Schizophr Res       Date:  2009-03-27       Impact factor: 4.939

10.  Reduction of caudate nucleus volumes in neuroleptic-naïve female subjects with schizotypal personality disorder.

Authors:  Min-Seong Koo; James J Levitt; Robert W McCarley; Larry J Seidman; Chandlee C Dickey; Margaret A Niznikiewicz; Martina M Voglmaier; Payman Zamani; Katherine R Long; Sunnie S Kim; Martha E Shenton
Journal:  Biol Psychiatry       Date:  2006-02-07       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.